Results

Found 544 hits.

Search Results for: L3M2 Studienmaterialien: Ethical Procurement and Supply - L3M2 Torrent Prüfung - L3M2 wirkliche Prüfung 🍱 Suchen Sie auf ( www.itzert.com ) nach 《 L3M2 》 und erhalten Sie den kostenlosen Download mühelos 🙁L3M2 Prüfungs-Guide – Page 19

How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches

9. Biró, T., Ko, M. C., Bromm, B., Wei, E. T., Bigliardi, P., Siebenhaar, F., Hashizume, H., Misery, L., Baserga, N., Kamei, C., Schouenborg, J., Roostermann, D., Szabó, T., Maurer, M., Bigliardi-Qi, M., Meingassner, J. G., Hossen, M. A., Schmelz, M., and Steinhoff, M.: How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp. Dermatol. 2005: 14; 225-240. IF: 2.09
more »

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase

114 Maurer, M.+ Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S, Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., Jung, A., Kleine-Tebbe, J., Mempel, M., Meurer, M., Reich, K., Ruëff, F., Sengupta, K., Sieder, C., Simon, J. C., Wedi, B., Zuberbier, T., Mahler, V., and Staubach, P.: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin. Immunol. 2011: 128; 202-209. IF: 11.00

o.114

more »

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU

318 Sussman, G.+, Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez-Arnau, A., Grattan, C., Hollis, K., Hunter, S., Knulst, A., Lacour, J. P., Lynde, C., Marsland, A., McBride, D., Maurer, M. Nakonechna, A., Ortiz de Frutos, J., Reynolds, M., Sweeney, C., Tian, H., Weller, K., Wolin, D., and Balp, M. M.: Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy 2018: 73; 1724-1734. IF: 6.77
more »